Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes.

Kanamori, Takehiro; Takeshita, Yumie; Isobe, Yuki; Kato, Ken-Ichiro; Misu, Hirofumi; Kaneko, Shuichi; Takamura, Toshinari

Kanamori, Takehiro; Takeshita, Yumie; Isobe, Yuki; Kato, Ken-Ichiro; Misu, Hirofumi; Kaneko, Shuichi; Takamura, Toshinari.

Afiliação

Kanamori T; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Takeshita Y; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Isobe Y; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Kato KI; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Misu H; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Kaneko S; Department of System Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Takamura T; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

BMJ Open Diabetes Res Care ; 6(1): e000588, 2018.

Article em En | MEDLINE | ID: mdl-30487974